GENITOURINARY CANCER
Maha H. Hussain, MB ChB
University of Michigan Comprehensive Cancer Center
Translates scientific discoveries into clinical advances
Acceptance Speech
    Maha H. Hussain, MB ChB, is the Cis Maisel Professor of Oncology and a professor of medicine and urology at the University of Michigan. She serves as the associate director for Clinical Research and co-leader of the Prostate Cancer/GU Oncology Program at the University of Michigan Comprehensive Cancer Center (UMCCC). Her work and accomplishments include:
    • Contributed to research that led to the FDA approval of docetaxel for the treatment of men with advanced prostate cancer
    • As lead investigator, evaluated optimal schedules of androgen deprivation therapy for patients with newly diagnosted metastatic prostate cancer through an international collaborative trial
    • Pioneered novel clinical trials in bladder and prostate cancer
    • Guided national research through various leadership positions, including as co-chair of the Prostate Cancer subcommittee of SWOG GU committee, as a member and 2013 chair of the Integration Panel (IP) of US Army Medical Research and Materiel Command Prostate Cancer Research Program, and as a member of the NCI-Cancer Biomarker Study Section and the NCI´s prostate cancer task force
    • Serves as an FDA consultant and has served as a member and chair of the FDA Oncology Drug Advisory Committee
    • Served/serves on the editorial boards of several national and international specialty publications, including the Journal of Clinical Oncology and the American Journal of Translational Research
    • Honored with the University of Michigan Medical School League of Research Excellence award and the 2012 Clinical & Health Services Research award
Program Information:
Nominate
Sponsor
News
Previous Inductees:
2013 | 2014
2015 | 2016
2017 | 2018
Connect: